TermGallery
Inglés
Inglés
Español
Catalán
Portugués
Ruso
ES
English
Español
Català
Português
Русский
portugués
carcinoma ductal invasivo sem outra especificação
español
carcinoma ductal infiltrante
Human disease.
invasive ductal adenocarcinoma
infiltrating ductal adenocarcinoma
infiltrating ductal carcinoma of breast
invasive ductal breast carcinoma
infiltrating ductal carcinoma of the breast
invasive ductal carcinoma of the breast
infiltrating ductal carcinoma
invasive ductal carcinoma
invasive ductal carcinoma of breast
infiltrating ductal breast carcinoma
español
carcinoma ductal infiltrante
1
Hypoxia contributes to the aggressive and treatment-resistant phenotype of pancreatic
ductal
adenocarcinoma
.
2
Conclusions: This paper emphasizes the grim prognosis of pancreatic
ductal
adenocarcinoma
.
3
Purpose: To evaluate imaging findings of diffuse pancreatic
ductal
adenocarcinoma
.
4
HG-PanIN mutation profiles were compared with those of their associated invasive pancreatic
ductal
adenocarcinoma
.
5
Methods: We prospectively collected data on the families of patients presenting with pancreatic
ductal
adenocarcinoma
.
6
A literature search revealed only 3 prior reports of primary
ductal
adenocarcinoma
of the lacrimal gland.
7
To test our hypothesis, we have used Panc1 cells, which is a pancreatic
ductal
adenocarcinoma
cell type.
8
Maspin may be helpful in differentiating
ductal
adenocarcinoma
from chronic pancreatitis, once squamous metaplasia is ruled out.
9
Assessment of PTEN expression may be used as a prognostic marker for patients with resected pancreatic
ductal
adenocarcinoma
.
10
The identity of the cell of origin for pancreatic
ductal
adenocarcinoma
(PDAC) has long been debated.
11
Pancreatic
ductal
adenocarcinoma
(PDAC) is an aggressive malignancy and is highly resistant to standard treatment regimens.
12
We aimed to identify stress-associated molecular responses to PL treatment in pancreatic
ductal
adenocarcinoma
(PDAC) cells.
13
Pancreatic
ductal
adenocarcinoma
(PDAC) is an aggressive malignancy characterized by extensive local invasion and systemic spread.
14
Pancreatic
ductal
adenocarcinoma
(PDA) remains one of the most aggressive tumors with a low rate of survival.
15
Pancreatic
ductal
adenocarcinoma
(PDAC) is one of the most aggressive cancers associated with high morbidity and mortality.
16
Pancreatic
ductal
adenocarcinoma
(PDAC) is one of the leading causes of cancer death in the Western world.
ductal
adenocarcinoma
ductal
portugués
carcinoma ductal invasivo sem outra especificação
español
carcinoma ductal infiltrante